The move by Merrill Lynch, the US-based investment banking brokerage, to bar its analysts from holding shares in any of the companies they cover has been greeted with scepticism by research heads at rival firms.

This comes at a time when the investment industry has been questioning the independence of many analysts' Buy and Sell views, particularly where a bank might have other relationships with a company.